Investor Relations

Presenter:
Pierluigi Paracchi, CEO and Co-founder Genenta Science
Carlo Russo, CMO Genenta Science

Pierluigi Paracchi CEO Genenta joins Proactive to talk about its clinical-stage biotechnology company. The Nasdaq-listed firm is pioneering the development of a proprietary hematopoietic stem cell therapy for the treatment of a variety of solid tumour cancers.

MILAN, Italy, July 25, 2022 (GLOBE NEWSWIRE) -- Bowling Green Bull (BGB) is an initiative to connect Italian companies, entrepreneurs and top managers aiming for international growth and expansion in their interactions with U.S. financial markets and investors.